Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum94344Research ArticleFeatures of airway microbiota in smoking patients: predictors of form factors-resistant microfloraFrolovaA. Kak_frolova@mail.ruKaramovaF. Afakaram@yandex.ruSholomovI. Fsholomovigor@rambler.ruN.I.Pirogov Russian Research Medical University of the Ministry of Health of the Russian FederationTyumen State Medical University of the Ministry of Health of the Russian Federation151120151711313428122021Copyright © 2015, Consilium Medicum2015This article contains information about the effects of smoking on the state of human respiratory tract microflora. Respiratory infections in Russia are a significant problem and, although on a large amount of scientific data and practical advice, practical public health physicians each year have problems of diagnosis and treatment of bacterial infections of the respiratory tract. First of all, it is bacterial pneumonia, which requires the appointment of antibacterial therapy, the choice of which depends on the etiologic factor. Taking into account the data of the respiratory tract microflora in smokers, it is possible to optimize the assignment of antibacterial agents in the treatment of pneumonia, exacerbation of chronic obstructive pulmonary disease and other bacterial infections of the respiratory tract.smokingrespiratory tract microflorabacterial infections of the respiratory tractкурениемикрофлора дыхательных путейбактериальные респираторные инфекции[Brook I, Gober A.E. Recovery of potential pathogens and interfering bacteria in the nasopharynx of smokers and nonsmokers. Chest 2005; 127 (6): 2072-5.][European health for all database (HFA-DB) World Health Organization Regional Office for Europe. 2010.][Global Tobacco Surveillance System (GTSS). Global Adult Tobacco Survey (GATS): Sample Design Manual. 2009.][Helminen M.E, Maciver I, Latimer J.L et al. A Large, Antigenically Conserved Protein on the Surface of Moraxella catarrhalis Is a Target for Protective Antibodies. J Infect Dis. 1994; 170 (4): 867-72.][Jacoby G.A. Prevalence and resistance mechanisms of common bacterial respiratory pathogens. Clin Infect Dis 2012; 18: 951-7.][Judy S. Parents who smoke put their children at risk of infections. BMJ 2006; 332: 628.][Lopez A. Tobacco is unique in its killing ability. Smokefree Europe. A Forum for Networks. Key Trends for 2000 and beyond. Conference on Tobacco or Health. Helsinki, Finland, 1996, 2-4 October; p. 122-8.][Maciver I, Unhanand M, Mc Cracken G.H.Jr, Hansen E.J. Effect of Immunization on Pulmonary Clearance of Moraxella Catarrhalis in an Animal Model. J Infect Dis 1993; 168 (2): 469-72.][Mawas F, Ho M.M, Corbel M.J. Current progress with Moraxella catarrhalis antigens as vaccine candidates. Expert Rev Vaccines 2009; 8 (1): 77-90.][Melendez P.R, Johnson R.H. Bacteremia and Septic Arthritis Caused by Moraxella catarrhalis. Rev Infect Dis 1991; 13 (3): 428-9.][Tamang M.D, Dey S, Makaju R.K et al. Prevalence of Moraxella catarrhalis infections of the lower respiratory tract in elderly patients. Kathmandu Univ Med J 2005; 3 (1, Issue 9): 39-44.][Jacobs M.R, Felmingham D, Appelbaum P.C et al. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community - acquired respiratory tract infections to commonly used antimicrobial agents. J Antimicrob Chemother 2000; 45: 191-203.][Winstanley T.G, Spencer R.C. Moraxella catarrhalis: antibiotic susceptibility with special reference to trimethoprim. J Antimicrob Chemother 1986; 18 (3): 425-6.][World Health Organization, Geneva. WHO Report on the Global Tobacco Epidemic. 2009.][Yu S, Gu X.X. Biological and Immunological Characteristics of Lipooligosaccharide- Based Conjugate Vaccines for Serotype C Moraxella catarrhalis. Infect Immun 2007; 75 (6): 2974-80.][Акимова А.В., Андреев А.Н., Юферева Е.В. Курение и хронические заболевания органов дыхания и кровообращения у лиц старше 40 лет. Здоровье и образование в XXI веке. 2010; 12 (1): 57-8.][Бабанов С.А. Роль табакокурения в развитии хронических неспецифических заболеваний легких (обзор литературы). Здравоохранение Российской Федерации. 2002; 1: 53-5.][Барбараш Н.А., Барбараш Л.С., Барбараш О.Л. и др. Курение и сердечно - сосудистая система. КардиоСоматика. 2013; 4: 44-7.][Кирилловых А.А. Новое антитабачное законодательство и меры по ограничению курения табака. Право и экономика. 2013; 12 (310): 19-23.][Киселева Е.А., Кокосов А.Н., Зарембо И. А. Курение табака и преодоление табачной зависимости. Аллергология. 2005; 4: 10-4.][Кречикова О.И. и др. Выделение, идентификация и определение чувствительности к антибиотикам Streptococcus pneumoniae. Клин. микробиология и антимикробная химиотерапия. 2000; 2 (1): 88-98.][Ланкина М.В. Микрофлора зева человека как показатель определения резистентности организма. Микробиология. 2002; 3: 97-9.][Миронов А.Ю. Условно - патогенные микроорганизмы при заболеваниях дыхательных путей у больных региона Московской области. Микробиология. 2000; 1: 81-4.][Пульмонология. Национальное руководство. Краткое издание. Под ред. А.Г.Чучалина. М.: ГЭОТАР-Медиа, 2013.][Чучалин А.Г. Белая книга. Пульмонология. Россия 2003. М., 2003.][Чучалин А.Г., Синопальников А.И., Чернеховская Н.Е. Пневмония. М., 2002; с. 480.]